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Key Messages
1. The Mycobacterium	tuberculosis	
glutamate synthase consisting 
of alpha and beta subunits can 
be purified in a heterologous 
Escherichia	 coli	 expression 
system.
2. The beta subunit can be 
expressed in the soluble protein 
fraction under low temperature 
conditions.
3. The alpha subunit enters 
inclusion bodies in E	coli but can 
be refolded and subsequently 
purified.
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Introduction
Tuberculosis is a contagious disease mainly caused by the infection of 
high guanine plus cytosine content Gram-positive mycobacteria, mainly 
Mycobacterium	 tuberculosis. According to the World Health Organization 
(WHO) 2007 Tuberculosis Facts, the annual incidences of tuberculosis are stable 
or falling in all six WHO regions and have peaked globally.1,2 Nonetheless, the 
total number of cases in developing countries is still increasing. Tuberculosis 
remains a leading cause of death worldwide and is a potentially lethal infectious 
disease in Hong Kong. 
 The complete genome sequence of M	 tuberculosis enables better 
understanding of this bacterium and the potential targets that may be useful 
in therapeutic interventions. By using postgenomic methods, identification of 
essential genes opened a window of opportunity to pursue novel therapeutic 
strategies to develop antituberculosis agents. Recent research identified a group 
of essential genes based on a postgenomic in	 silico approach, and suggested 
that the glutamate synthase is one of the essential genes in the M	tuberculosis 
life cycle.3 As both large and small subunits of glutamate synthase, gltB and 
gltD respectively, are absent from the human genome, targeting the glutamate 
synthase may be an excellent means of treating tuberculosis. This study may 
provide the foundation for new therapeutic strategies against tuberculosis, by 
cloning and purifying both subunits of the M	tuberculosis glutamate synthase. 
Methods
This study was conducted from January to June 2007. The E	coli	strain TOP10 
was used for gene cloning and deoxyribonucleic acid (DNA) sequencing, whereas 
BL21 (DE3) was used for protein expression. pGEM-T Easy Vector (Promega, 
USA) was used for cloning polymerase chain reaction (PCR) products, whereas 
pET-28a(+) vector (Novagen, USA) was used for protein expressions.
 Oligonucleotide primers were purchased from Tech Dragon Limited in Hong 
Kong, and DNA sequencing was also performed by this company. Amplification 
of PCR was performed with Pwo SuperYield DNA Polymerase (Roche) using 
genomic DNA of M	tuberculosis	H37Rv provided by colleagues. The gltB and 
gltD	 open reading frames were amplified by PCR. The PCR products were 
cloned into pGEM-T Easy Vector (Promega) and then transformed into E	coli 
strain TOP10 for propagating plasmids and then cloned into the NheI/HindIII 
site of pET-28a(+) Vector (Novagen) to yield plasmid pET28a-gltB, pET28a-
gltD and pET28a-gltBD for protein expressions in E	coli strain BL21 (DE3). 
 Plasmids pET28a-gltB and pET28a-gltD that encoded the α and β subunits 
of glutamate synthase were transformed into E	coli BL21 (DE3). The cells were 
maintained in LB broth supplemented with 50 μg/mL of kanamycin. For protein 
expression, 1 M of IPTG was added to the culture to a final concentration of 0.5 
mM IPTG to induce protein expression when the cells grow to the log phase 
(OD
600
≈0.6). The cells were further incubated at room temperature or 37ºC for 
protein expression. For protein expression with addition of chemical chaperones, 
different concentrations of dimethyl sulfoxide and 4-phenylbutyric acid were 
added to the culture before IPTG induction.
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 After expression of proteins, cells were pelleted 
by centrifugation and extraction buffer (50 mM Tris, 
pH 7.5, 0.3 M NaCl, 20 mM imidazole, and 10 mM 
β-mercaptoethanol, 1% Triton-X 100, 1X protease inhibitor 
cocktail [Roche]) was added to the pellet in a 1:100 ratio. 
The cell suspension was incubated on ice for 30 minutes and 
then sonicated by a tip probe sonicator. The soluble protein 
fraction and insoluble protein fraction were separated by 
centrifugation. For refolding of the α subunit, the insoluble 
fraction was dissolved in solubilising buffer (6 M urea, 50 
mM Tris, pH 7.5, 20 mM imidazole, 0.3 M NaCl, 10 mM 
β-mercaptoethanol, 1X protease inhibitor cocktail [Roche]) 
in a 1:50 ratio. The solublised proteins was then rapidly 
diluted in 1 L of extraction buffer for protein refolding. This 
protein solution was centrifuged at 24000x g to remove the 
insoluble fraction, and the supernatant was collected for 
protein purification.
 Both of the subunits were purified by using HisTrap 
FF column (Amersham Biosciences). The column was 
equilibrated in a 3 bed volume of 20 mM imidazole in 
elution buffer (50 mM Tris, pH 7.5, 0.3 M NaCl, 10 mM 
β-mercaptoethanol, 1% Triton-X 100, 1X protease inhibitor 
cocktail [Roche]), and then the protein solution was loaded 
on the column. For the α subunit, a column was washed 
with 50 mM imidazole in elution buffer, and the α subunit 
was eluted using 300 mM imidazole in elution buffer. For 
the β subunit, a column was washed by 75 mM imidazole 
in elution buffer, and the β subunit was eluted using 100 
mM imidazole in elution buffer. Regarding screening for 
the protein expressions with added chemical chaperones, 
Ni-NTA Magnetic Agarose Beads (Qiagen) were used for 
purification of the α subunit. The purification step was 
carried out according to the manufacturer’s instructions. 
Briefly, the soluble fraction of the cell extracts were loaded 
on the pre-washed beads and the beads were washed by 
extraction buffer. Subsequently, proteins were eluted using 
500 mM imidazole in elution buffer. The purification of 
α and β subunits of glutamate synthase were analysed by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis.
 Glutamate synthase activity was detected by the assay 
described by Miller and Stadtman in 1972 with some 
modifications.1 Glutamate synthase activity was determined 
by measuring the rate of oxidation of NADPH at 340 nm. 
Standard assay mixtures (250 μL) contained 0.16 mM 
NADPH, 1 mM α-ketoglutaric acid, 2 mM L-glutamine, 
1 mM EDTA, 50 mM potassium phosphate buffer, pH 7.5, 
and sufficient enzyme to produce an absorbance change at 
340 nm at 30ºC. 
 The absorbance at 280 nm and 440 nm were detected 
by spectrophotometer at room temperature. Also, for 
the detection of the flavin bound to the subunits, the 
emission spectrum of the purified subunits were recorded 
between 450 and 600 nm with excitation at 440 nm in a 
spectrofluorometer.2
Results
The glutamate synthase consisted of two subunits, GltB 
and GltD, which were cloned and purified independently. 
The genes were cloned and ligated into a heterologous 
protein expression vector in E	 coli using a hexahistidine 
tag for facile purification. The α subunit misfolded upon 
expression in E	coli,	but refolding and purification of the 
alpha subunit of the protein was successfully performed 
(Fig 1a). The β subunit expressed in the soluble form under 
low temperature expression conditions and was expressed 
and purified successfully, using immobilised metal affinity 
chromatography (Fig 1b). 
Discussion
Previous research had identified a group of essential genes 
using a postgenomic in	silico approach, and suggested that 
the glutamate synthase was an essential gene for the M	
tuberculosis life cycle.3 By comparing the deduced amino 
acid sequences of M	tuberculosis	gltB	and gltD	with other 
Figure	1.	Purification of the α and β subunits of glutamate synthase 
using nickel affinity chromatography column: (a) purifying refolds 
the α subunit, whereby the α subunit is eluted using 100 mM to 
200 mM imidazole in elution buffer; (b) purifying the soluble β 
subunit, where the β subunit is eluted using 100 mM imidazole in 
elution buffer.
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mycobacteria, it was inferred that these proteins were highly 
conserved. This suggested that the cloning and expression 
of glutamate synthase genes might provide a foundation 
for the development of inhibitors against Mycobacterium 
growth.
 We aimed to express the relevant glutamate synthase in 
a soluble and functional form. However, only the β subunit 
could be expressed in a soluble form. Even with assistance 
of chemical chaperones, the α subunit was expressed as an 
insoluble fraction. We therefore refolded the protein before 
purification. 
 Previous studies suggested that glutamate synthase was 
a multicomponent iron-sulphur flavoprotein, composed 
of two dissimilar subunits (α and β). The α subunit was 
believed to contain one flavin mononucleotide and β subunit 
one flavin adenine dinucleotide (FAD). As the glutamate 
synthase activity depends on the cooperation of both flavin 
co-factors, which the β subunit serves to transfer reducing 
equivalents from NADPH to the FMN co-factor through the 
FAD co-factor and the iron-sulfur cluster. Therefore, loss 
of co-factor during refolding may lead to loss of glutamate 
synthase activity. We also noted that in future we should 
scan the atomic absorption spectrum of both subunits to 
assess whether the iron-sulfur clusters persist in the purified 
glutamate synthase. 
 In this project, we successfully cloned the subunits, gltB 
and gltD, of glutamate synthase and the proteins encoded 
by these two open reading frames were expressed in E	coli	
BL21 (DE3). The α subunit was expressed in an insoluble 
form and the β subunit as a soluble fraction. We were able 
to purify the α subunit after refolding. Further studies are 
required to fully characterise the purified and reconstituted 
enzyme before targeting this protein as part of a therapeutic 
strategy against tuberculosis. 
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